首页 > 最新文献

Uroonkoloji Bulteni-Bulletin of Urooncology最新文献

英文 中文
Bellini Duct Carcinoma: Case Report and Review of the Literature 贝利尼管癌:病例报告及文献复习
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-30 DOI: 10.4274/UOB.693
G. Dundar, E. Korgalı
{"title":"Bellini Duct Carcinoma: Case Report and Review of the Literature","authors":"G. Dundar, E. Korgalı","doi":"10.4274/UOB.693","DOIUrl":"https://doi.org/10.4274/UOB.693","url":null,"abstract":"","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"170-173"},"PeriodicalIF":0.2,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70977630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Presence and Thickness of Pseudocapsule after Partial Nephrectomy in Renal Cell Carcinoma 肾细胞癌部分切除后假包膜的存在及厚度
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-30 DOI: 10.4274/UOB.704
F. Narter, F. Tarhan, E. Çamur, S. Sarikaya, K. Başak, M. Tuncer, İstem Köse, Aydın Özgül
Ya z›fl ma Ad re si/Ad dress for Cor res pon den ce: Dr. Fehmi Narter, Kartal Dr. Lutfi Kirdar Egitim ve Arastirma Hastanesi, Uroloji Klinigi, Istanbul, Turkiye E-mail: fehminarter66@gmail.com Ge lis Ta ri hi/Re cei ved: 20.06.2016 Ka bul Ta ri hi/Ac cep ted: 05.09.2016 © Uroonkoloji Bulteni, Ga le nos Ya yi ne vi ta ra fin dan ba sil mis tir. Bu makale “Creative Commons Alinti-Gayriticari-Turetilemez 4.0 Uluslararasi Lisansi (CC BY-NC 4.0)” ile lisanslanmistir. Objective: In this study, we aimed to evaluate the presence and thickness of pseudocapsule after partial nephrectomy in renal cell carcinoma (RCC) cases. Materials and Methods: A total of 100 patients who were admitted to our clinic and diagnosed with RCC were included in the study. Histopathological specimens of the patients who underwent partial nephrectomy were re-evaluated retrospectively. Results: The histopathological results revealed pseudocapsule in 87 cases (87%, median thickness: 0.708 mm). Pseudocapsule median thickness was noted respectively 0.483, 0.691, 0.737, 0.954 mm in Fuhrman Grade 0, 1, 2, 3/4 groups (p<0.05). Conclusion: In this study, a statistical significance was found between nuclear grading system and the thickness of pseudocapsule in RCC. We believe that it may be a prognostic factor for RCC in the future.
Ya z / fl ma Ad re si/Ad dress for Cor res pon den ce: Dr. Fehmi Narter, Kartal Dr. Lutfi Kirdar Egitim ve Arastirma Hastanesi, Uroloji Klinigi, Istanbul, Turkiye E-mail: fehminarter66@gmail.com Ge lis Ta ri hi/接收:2016年6月20日Ka bul Ta ri hi/Ac接收:2016年5月9日©Uroonkoloji Bulteni, Ga le nos Ya yi ne vi, ra fin dan仍在使用。但是要使“Creative Commons Alinti-Gayriticari-Turetilemez 4.0 Uluslararasi Lisansi (CC BY-NC 4.0)”成为lisanslanmistir。目的:探讨肾细胞癌部分切除后假包膜的存在及厚度。材料与方法:本研究共纳入我院收治的100例确诊为肾细胞癌的患者。对行部分肾切除术患者的组织病理标本进行回顾性评价。结果:组织病理学检查显示假包膜87例(87%),中位厚度0.708 mm。Fuhrman分级0、1、2、3/4组假包膜中位厚度分别为0.483、0.691、0.737、0.954 mm (p<0.05)。结论:核分级系统与RCC假包膜厚度之间有统计学意义。我们认为这可能是未来肾细胞癌的一个预后因素。
{"title":"The Presence and Thickness of Pseudocapsule after Partial Nephrectomy in Renal Cell Carcinoma","authors":"F. Narter, F. Tarhan, E. Çamur, S. Sarikaya, K. Başak, M. Tuncer, İstem Köse, Aydın Özgül","doi":"10.4274/UOB.704","DOIUrl":"https://doi.org/10.4274/UOB.704","url":null,"abstract":"Ya z›fl ma Ad re si/Ad dress for Cor res pon den ce: Dr. Fehmi Narter, Kartal Dr. Lutfi Kirdar Egitim ve Arastirma Hastanesi, Uroloji Klinigi, Istanbul, Turkiye E-mail: fehminarter66@gmail.com Ge lis Ta ri hi/Re cei ved: 20.06.2016 Ka bul Ta ri hi/Ac cep ted: 05.09.2016 © Uroonkoloji Bulteni, Ga le nos Ya yi ne vi ta ra fin dan ba sil mis tir. Bu makale “Creative Commons Alinti-Gayriticari-Turetilemez 4.0 Uluslararasi Lisansi (CC BY-NC 4.0)” ile lisanslanmistir. Objective: In this study, we aimed to evaluate the presence and thickness of pseudocapsule after partial nephrectomy in renal cell carcinoma (RCC) cases. Materials and Methods: A total of 100 patients who were admitted to our clinic and diagnosed with RCC were included in the study. Histopathological specimens of the patients who underwent partial nephrectomy were re-evaluated retrospectively. Results: The histopathological results revealed pseudocapsule in 87 cases (87%, median thickness: 0.708 mm). Pseudocapsule median thickness was noted respectively 0.483, 0.691, 0.737, 0.954 mm in Fuhrman Grade 0, 1, 2, 3/4 groups (p<0.05). Conclusion: In this study, a statistical significance was found between nuclear grading system and the thickness of pseudocapsule in RCC. We believe that it may be a prognostic factor for RCC in the future.","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"136-139"},"PeriodicalIF":0.2,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70977924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Clinical, Oncological, Functional and Surgical Outcomes of Patients Who Underwent Adrenalectomy 肾上腺切除术患者的临床、肿瘤、功能和手术结果
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-30 DOI: 10.4274/UOB.691
Ünsal Eroğlu, M. Koparal, I. Üre, S. Çetin, E. C. Bulut, C. Acar, T. Sözen
Summary Oz Results: A total of 88 patients with adrenal masses were endocrinologically evaluated. Fifty nine (67%) patients had functional masses and 29 (33%) patients had non-functional masses. Open transabdominal adrenalectomy and laparoscopic adrenalectomy were performed in 20 (22.7%) and 68 (77.3%) patients, respectively. According to the results of histopathological evaluation, benign and malignant masses were determined in 79 (89.7%) and nine (10.3%) patients, respectively. Bleeding amount and mass size were significantly higher in patients with malignant masses and in patients with functional masses (p=0.003 and p=0.002; p=0.007 and p=0.004, respectively). The duration of operation and hospitalization were significantly longer, and peri-operative complication and blood transfusion rates were significantly higher in patients with malignant masses (p=0.006 and p=0.003; p=0.027 and p=0.001, respectively). Neither functionality nor pathology of adrenal masses had a statistically significant relationship with ASA score and BMI.
结果:共88例肾上腺肿块患者进行了内分泌学评估。59例(67%)为功能性肿块,29例(33%)为非功能性肿块。经腹切开肾上腺切除术20例(22.7%),腹腔镜肾上腺切除术68例(77.3%)。根据组织病理学评估结果,良性肿块79例(89.7%),恶性肿块9例(10.3%)。恶性肿块患者的出血量和肿块大小明显高于功能性肿块患者(p=0.003和p=0.002;P =0.007和P =0.004)。恶性肿物患者手术时间和住院时间均明显延长,围手术期并发症和输血率均明显高于恶性肿物患者(p=0.006和p=0.003;P =0.027和P =0.001)。肾上腺肿物的功能和病理与ASA评分和BMI均无统计学意义。
{"title":"The Clinical, Oncological, Functional and Surgical Outcomes of Patients Who Underwent Adrenalectomy","authors":"Ünsal Eroğlu, M. Koparal, I. Üre, S. Çetin, E. C. Bulut, C. Acar, T. Sözen","doi":"10.4274/UOB.691","DOIUrl":"https://doi.org/10.4274/UOB.691","url":null,"abstract":"Summary Oz Results: A total of 88 patients with adrenal masses were endocrinologically evaluated. Fifty nine (67%) patients had functional masses and 29 (33%) patients had non-functional masses. Open transabdominal adrenalectomy and laparoscopic adrenalectomy were performed in 20 (22.7%) and 68 (77.3%) patients, respectively. According to the results of histopathological evaluation, benign and malignant masses were determined in 79 (89.7%) and nine (10.3%) patients, respectively. Bleeding amount and mass size were significantly higher in patients with malignant masses and in patients with functional masses (p=0.003 and p=0.002; p=0.007 and p=0.004, respectively). The duration of operation and hospitalization were significantly longer, and peri-operative complication and blood transfusion rates were significantly higher in patients with malignant masses (p=0.006 and p=0.003; p=0.027 and p=0.001, respectively). Neither functionality nor pathology of adrenal masses had a statistically significant relationship with ASA score and BMI.","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"129-135"},"PeriodicalIF":0.2,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70977613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Controversies in Radical Cystectomy: Meta-Analysis and Systemic Comparison of Open Surgery with Laparoscopic and Robotic Surgery 根治性膀胱切除术的争议:开放手术与腹腔镜和机器人手术的meta分析和系统比较
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-23 DOI: 10.4274/UOB.542
M. Kaynar, S. Goktas
Kas invaziv ve yüksek riskli invaziv olmayan mesane kanserlerinin tedavisinde açık radikal sistektomi (ARS) standart tedavi yöntemidir. ARS avantajlı onkolojik sonuçlarına rağmen yüksek morbidite ve mortalite oranlarına sahiptir. Son yıllarda üroteknolojideki gelişmeler ile birlikte minimal invaziv tedavi seçeneklerinden laparoskopik radikal sistektomi (LRS) ve robot yardımlı radikal sistektomi (RYRS) mesane tümörlerinin tedavisinde ARS’ye alternatif olarak ortaya çıkmıştır. Her iki yöntemin etkin cerrahi ve benzer onkolojik sonuçlarının olduğu çeşitli çalışmalarda gösterilmiştir. Fakat LRS’deki uygulama zorluğu ve RYRS’deki yüksek maliyetler nedeni ile yaygınlaşması kısıtlanmaktadır. Deneyimli merkezlerin uygulamalarının yanında genel popülasyona dayalı geniş hasta serilerini içeren uzun süreli onkolojik sonuçların karşılaştırmalı olarak ortaya konması ile birlikte invaziv mesane tümörlerinin standart tedavisindeki manzaranın değişmesi kaçınılmaz görünmektedir. Anahtar Kelimeler: Mesane kanseri, laparoskopi, robotik cerrahi, sistektomi Open radical cystectomy (ORC) is the standard treatment modality in high-risk non-muscle-invasive and invasive bladder carcinoma. Although it has some advantages, oncologic outcomes of ORC are associated with high morbidity and mortality risks. In line with recent developments in urotechnology, the minimally invasive treatment modalities, such as laparoscopic radical cystectomy (LRC) and robotic-assisted radical cystectomy (RARC) have emerged as an alternative to ORC. Compared to ORC, both treatment modalities have effective surgical and similar oncological outcomes as reported in various studies. However, due to inherent difficulties in the practice of LRC and high costs of RRC have hindered these two treatment modalities to become widespread. Considering the results obtained in experienced centers as well as longterm oncologic outcomes of large patient series forming samples of the whole population, changes in the standard treatment modality of invasive bladder tumors seem to be unavoidable.
ARS是治疗无创和非高危网状癌症的标准方法。ARS具有很高的发病率和死亡率,即使具有肿瘤学的优势。Son yıllardaüroteknolojideki gelişmeler ile birlikte minimum invaziv tedavi seçeneklerinden laparoskopik radikal sistektomi(LRS)ve robot yardımlıradikal ssistektomi(RYRS)mesane tümörlerinin tedavisinde ARS’ye alternatif olaak ortayaçıkmıştır。这两种方法已经在各种研究中得到了证明,在这些研究中,手术和类似的肿瘤学结果都有影响。但是LRS和RYRS的应用难度是有限的。随着实验中心的应用,普通人群似乎可以避免将长期肿瘤学后果与侵袭性台面肿瘤的标准治疗进行比较。关键词:Mesane癌症、腹腔镜、机器人cerrahi、开放性根治性膀胱切除术(ORC)是高风险非肌肉浸润性和侵袭性膀胱癌的标准治疗方式。尽管它有一些优点,但ORC的肿瘤学结果与高发病率和死亡率风险相关。根据尿路技术的最新发展,微创治疗模式,如腹腔镜根治性膀胱切除术(LRC)和机器人辅助根治性膀胱摘除术(RARC)已成为ORC的替代方案。与ORC相比,这两种治疗方式都具有有效的手术效果,并且在各种研究中报告的肿瘤学结果相似。然而,由于LRC实践中固有的困难和RRC的高成本阻碍了这两种治疗模式的普及。考虑到在经验丰富的中心获得的结果,以及形成整个人群样本的大型患者系列的长期肿瘤学结果,浸润性膀胱肿瘤的标准治疗模式的变化似乎是不可避免的。
{"title":"Controversies in Radical Cystectomy: Meta-Analysis and Systemic Comparison of Open Surgery with Laparoscopic and Robotic Surgery","authors":"M. Kaynar, S. Goktas","doi":"10.4274/UOB.542","DOIUrl":"https://doi.org/10.4274/UOB.542","url":null,"abstract":"Kas invaziv ve yüksek riskli invaziv olmayan mesane kanserlerinin tedavisinde açık radikal sistektomi (ARS) standart tedavi yöntemidir. ARS avantajlı onkolojik sonuçlarına rağmen yüksek morbidite ve mortalite oranlarına sahiptir. Son yıllarda üroteknolojideki gelişmeler ile birlikte minimal invaziv tedavi seçeneklerinden laparoskopik radikal sistektomi (LRS) ve robot yardımlı radikal sistektomi (RYRS) mesane tümörlerinin tedavisinde ARS’ye alternatif olarak ortaya çıkmıştır. Her iki yöntemin etkin cerrahi ve benzer onkolojik sonuçlarının olduğu çeşitli çalışmalarda gösterilmiştir. Fakat LRS’deki uygulama zorluğu ve RYRS’deki yüksek maliyetler nedeni ile yaygınlaşması kısıtlanmaktadır. Deneyimli merkezlerin uygulamalarının yanında genel popülasyona dayalı geniş hasta serilerini içeren uzun süreli onkolojik sonuçların karşılaştırmalı olarak ortaya konması ile birlikte invaziv mesane tümörlerinin standart tedavisindeki manzaranın değişmesi kaçınılmaz görünmektedir. Anahtar Kelimeler: Mesane kanseri, laparoskopi, robotik cerrahi, sistektomi Open radical cystectomy (ORC) is the standard treatment modality in high-risk non-muscle-invasive and invasive bladder carcinoma. Although it has some advantages, oncologic outcomes of ORC are associated with high morbidity and mortality risks. In line with recent developments in urotechnology, the minimally invasive treatment modalities, such as laparoscopic radical cystectomy (LRC) and robotic-assisted radical cystectomy (RARC) have emerged as an alternative to ORC. Compared to ORC, both treatment modalities have effective surgical and similar oncological outcomes as reported in various studies. However, due to inherent difficulties in the practice of LRC and high costs of RRC have hindered these two treatment modalities to become widespread. Considering the results obtained in experienced centers as well as longterm oncologic outcomes of large patient series forming samples of the whole population, changes in the standard treatment modality of invasive bladder tumors seem to be unavoidable.","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"107-112"},"PeriodicalIF":0.2,"publicationDate":"2016-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70976070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Prostate Specific Antigen Density for the Prediction of Radical Therapy Requirement in Localized Prostate Cancer 前列腺特异性抗原密度在预测局部前列腺癌根治需求中的作用
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-23 DOI: 10.4274/uob.701
Ozan Bozkurt, Kaan Çömez, Ozgur Gurboga, O. Demir, G. Aslan, A. Esen
{"title":"Role of Prostate Specific Antigen Density for the Prediction of Radical Therapy Requirement in Localized Prostate Cancer","authors":"Ozan Bozkurt, Kaan Çömez, Ozgur Gurboga, O. Demir, G. Aslan, A. Esen","doi":"10.4274/uob.701","DOIUrl":"https://doi.org/10.4274/uob.701","url":null,"abstract":"","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"103-106"},"PeriodicalIF":0.2,"publicationDate":"2016-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70977724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Early and Late Complications of Urinary Diversions after Radical Cystectomy 根治性膀胱切除术后尿改道的早期和晚期并发症
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-23 DOI: 10.4274/uob.577
U. Gonulalan, M. Koşan
{"title":"Early and Late Complications of Urinary Diversions after Radical Cystectomy","authors":"U. Gonulalan, M. Koşan","doi":"10.4274/uob.577","DOIUrl":"https://doi.org/10.4274/uob.577","url":null,"abstract":"","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"113-118"},"PeriodicalIF":0.2,"publicationDate":"2016-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70976855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Case: Contralateral Testicular Seminoma Accompanied by Right Undescended Testicle and Right Inguinal Hernia with Ipsilateral Renal Agenesis and Seminal Vesicle Agenesis 对侧睾丸精原细胞瘤合并右侧睾丸下位及右侧腹股沟疝合并同侧肾发育不全及精囊发育不全1例
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-23 DOI: 10.4274/UOB.551
Z. Demirer, A. Guragac, S. Uğuz, Bilal Fırat Alp, I. Yildirim
Unilateral veya bilateral olabilen seminal vezikül agenezisi (SVA) erkeklerde nadir infertilite sebepleridir. İnsidansı %0,6-1 olan unilateral SVA’ya renal agenezi (RA) ya da vaz deferens agenezisi (VDA) eşlik edebilir (1). Daha nadir izlenen bilateral SVA’da genellikle kistik fibrozis transmembran reseptör (KFTR) mutasyonu izlenir ve bilateral VDA ile birliktedir (1). Erkek reprodüktif sistemi ile üriner sisteminin embriyolojik ve anatomik olarak yakın ilişkide olmaları nedeniyle bu iki sisteme ait konjenital anomalilerde genellikle bir arada görülürler (1,2). Mezonefrik kanalın [(MK) Wolf kanalı] uygun gelişmemesi; böbrek, üreter, vaz deferans (VD) ve seminal vezikülün çeşitli konjenital anomalilerine sebep olabilmektedir (1,2). İnmemiş testis, testisin skrotum dışında, inguinal kesede, inguinal kanal dışında veya eksternal ringte palpe edilebilmesidir. İnmemiş testise en sık eşlik eden bozukluk inguinal herni olup, oluşumunda temel etken prosesus vajinalisin (PV) açık kalmasıdır (3). Biz burada sağ inguinal bölgede şişlik ve ağrı şikayetiyle merkezimize refere edilen; sağ inguinal herni ve sağ inmemiş testise, ipsilateral SVA ve ipsilateral RA’nın eşlik ettiği ayrıca sol testisinde seminom saptanan tedavi yönetimi oldukça zor olan bir olguyu sunduk.
具有开创性意义的视觉议程(SVA)可以是单侧的,也可以是双侧的,在男性中很少不孕。保险可以相当于0.6-1肾发育不全(RA)或vaz差异不全(VDA)的单侧SVA。在最罕见的双侧SVA中,观察到氧纤维化跨膜受体(KFTR)突变并与双侧VDA结合(1)。由于人类生殖系统与胚胎和生产系统的解剖结构密切相关,因此这两种属于该系统的常规异常通常一起出现(1.2)。中间相通道[(MK)Wolf通道]的发展是不合适的;肾脏、生产、vaz差异(VD)和精囊可能导致各种认知异常(1.2)。Il nmemiş睾丸、睾丸、腹股沟kesede、腹股沟kanal dışında veya eksternal ringte palpe edilefilmesidir。非感染测试中最常见的成分紊乱是缺乏基于PV的阴道过程(3)。我们在这里指的是我们的中心,抱怨在合适的环境中肥胖和疼痛;如果正确的成分不是正确的成分测试,我们在神学院障碍治疗的左侧测试中也提出了一个非常困难的流行病。
{"title":"A Rare Case: Contralateral Testicular Seminoma Accompanied by Right Undescended Testicle and Right Inguinal Hernia with Ipsilateral Renal Agenesis and Seminal Vesicle Agenesis","authors":"Z. Demirer, A. Guragac, S. Uğuz, Bilal Fırat Alp, I. Yildirim","doi":"10.4274/UOB.551","DOIUrl":"https://doi.org/10.4274/UOB.551","url":null,"abstract":"Unilateral veya bilateral olabilen seminal vezikül agenezisi (SVA) erkeklerde nadir infertilite sebepleridir. İnsidansı %0,6-1 olan unilateral SVA’ya renal agenezi (RA) ya da vaz deferens agenezisi (VDA) eşlik edebilir (1). Daha nadir izlenen bilateral SVA’da genellikle kistik fibrozis transmembran reseptör (KFTR) mutasyonu izlenir ve bilateral VDA ile birliktedir (1). Erkek reprodüktif sistemi ile üriner sisteminin embriyolojik ve anatomik olarak yakın ilişkide olmaları nedeniyle bu iki sisteme ait konjenital anomalilerde genellikle bir arada görülürler (1,2). Mezonefrik kanalın [(MK) Wolf kanalı] uygun gelişmemesi; böbrek, üreter, vaz deferans (VD) ve seminal vezikülün çeşitli konjenital anomalilerine sebep olabilmektedir (1,2). İnmemiş testis, testisin skrotum dışında, inguinal kesede, inguinal kanal dışında veya eksternal ringte palpe edilebilmesidir. İnmemiş testise en sık eşlik eden bozukluk inguinal herni olup, oluşumunda temel etken prosesus vajinalisin (PV) açık kalmasıdır (3). Biz burada sağ inguinal bölgede şişlik ve ağrı şikayetiyle merkezimize refere edilen; sağ inguinal herni ve sağ inmemiş testise, ipsilateral SVA ve ipsilateral RA’nın eşlik ettiği ayrıca sol testisinde seminom saptanan tedavi yönetimi oldukça zor olan bir olguyu sunduk.","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"123-126"},"PeriodicalIF":0.2,"publicationDate":"2016-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70976640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Prostatic Urethral Lift Method: A New Minimally Invasive Modality as an Alternative in the Treatment of Benign Prostatic Hyperplasia 前列腺尿道提升术:一种治疗良性前列腺增生的新微创方法
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-23 DOI: 10.4274/UOB.584
Alpaslan Yüksel, A. Tekin
{"title":"The Prostatic Urethral Lift Method: A New Minimally Invasive Modality as an Alternative in the Treatment of Benign Prostatic Hyperplasia","authors":"Alpaslan Yüksel, A. Tekin","doi":"10.4274/UOB.584","DOIUrl":"https://doi.org/10.4274/UOB.584","url":null,"abstract":"","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"119-122"},"PeriodicalIF":0.2,"publicationDate":"2016-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70976940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Relationship between Pathology Results and Pain Scores in Patients Who Underwent Transrectal Ultrasound-Guided Prostate 经直肠超声引导前列腺检查患者病理结果与疼痛评分关系的评价
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-23 DOI: 10.4274/UOB.666
D. Bolat, M. E. Aydın, B. Gunlusoy, T. Değirmenci, Y. K. Topcu, İbrahim Küçüktürkmen, Y. Ceylan, E. Şefik
© Üroonkoloji Bülteni, Ga le nos Ya yı ne vi ta ra fın dan ba sıl mış tır. Bu makale “Creative Commons Alıntı-Gayriticari-Türetilemez 4.0 Uluslararası Lisansı (CC BY-NC 4.0)” ile lisanslanmıştır. Objectives: In this study, we assessed the relationship between pain scores and the pathology results of patients who underwent transrectal ultrasound-guided prostate biopsy (TRUS-PBx). Materials and Methods: A total of 198 patients who underwent prostate biopsy between October 2014 and April 2015 due to abnormal digital rectal examination findings and/or high prostatespecific antigen (PSA) levels (≥2.5 ng/dL) were included in this study. Before the biopsy procedure, all patients underwent finger-guided transperineal periprostatic block with 10 mL of 2% prilocaine. A 10-point linear visual analogue scale (VAS) was used to assess the pain arising from probe insertion (VAS-1) and prostate sampling (VAS-2). After receiving the pathology results, the patients were grouped according to the presence of prostate cancer: Group 1: patients without prostate cancer and Group 2: patients with prostate cancer. Results: The mean age of the patients was 64±7.3 (43-83) years, and the mean PSA value was 12.5±18.3 (0.6-142) ng/dL. Prostate cancer detection rate was 22.7%. The mean VAS-1 score in Group 1 and group 2 was 1.6±1.8 and 2.0±2.5, respectively (p=0.209). The mean VAS-2 score in Group 1 and Group 2 was 2.5±2.4 and 2.6±2.6, respectively (p=0,725). Conclusion: The pain felt during TRUS-PBx is not related with the presence of prostate cancer on biopsy pathology.
©Üroonkoloji b lteni, Ga le nos Ya yylne vi ta ra fın dan ba sıl mış tır。但请参阅“知识共享Alıntı-Gayriticari-Türetilemez 4.0 uluslararasyi lisansyi (CC BY-NC 4.0)”网址lisanslanmıştır。目的:在本研究中,我们评估了经直肠超声引导前列腺活检(truss - pbx)患者疼痛评分与病理结果之间的关系。材料与方法:2014年10月至2015年4月期间因直肠指检异常和/或前列腺特异性抗原(PSA)水平高(≥2.5 ng/dL)而行前列腺活检的198例患者纳入本研究。在活检之前,所有患者都用10ml 2%的丙胺卡因进行手指引导的经会阴前列腺周围阻滞。采用10分线性视觉模拟量表(VAS)评估探针插入(VAS-1)和前列腺取样(VAS-2)引起的疼痛。收到病理结果后,将患者按有无前列腺癌进行分组:1组为无前列腺癌患者,2组为有前列腺癌患者。结果:患者平均年龄64±7.3(43 ~ 83)岁,平均PSA值12.5±18.3 (0.6 ~ 142)ng/dL。前列腺癌检出率为22.7%。1、2组VAS-1平均评分分别为1.6±1.8、2.0±2.5分(p=0.209)。1、2组VAS-2平均评分分别为2.5±2.4分、2.6±2.6分(p= 0.725)。结论:活检病理显示,前列腺癌与TRUS-PBx手术疼痛无关。
{"title":"Evaluation of the Relationship between Pathology Results and Pain Scores in Patients Who Underwent Transrectal Ultrasound-Guided Prostate","authors":"D. Bolat, M. E. Aydın, B. Gunlusoy, T. Değirmenci, Y. K. Topcu, İbrahim Küçüktürkmen, Y. Ceylan, E. Şefik","doi":"10.4274/UOB.666","DOIUrl":"https://doi.org/10.4274/UOB.666","url":null,"abstract":"© Üroonkoloji Bülteni, Ga le nos Ya yı ne vi ta ra fın dan ba sıl mış tır. Bu makale “Creative Commons Alıntı-Gayriticari-Türetilemez 4.0 Uluslararası Lisansı (CC BY-NC 4.0)” ile lisanslanmıştır. Objectives: In this study, we assessed the relationship between pain scores and the pathology results of patients who underwent transrectal ultrasound-guided prostate biopsy (TRUS-PBx). Materials and Methods: A total of 198 patients who underwent prostate biopsy between October 2014 and April 2015 due to abnormal digital rectal examination findings and/or high prostatespecific antigen (PSA) levels (≥2.5 ng/dL) were included in this study. Before the biopsy procedure, all patients underwent finger-guided transperineal periprostatic block with 10 mL of 2% prilocaine. A 10-point linear visual analogue scale (VAS) was used to assess the pain arising from probe insertion (VAS-1) and prostate sampling (VAS-2). After receiving the pathology results, the patients were grouped according to the presence of prostate cancer: Group 1: patients without prostate cancer and Group 2: patients with prostate cancer. Results: The mean age of the patients was 64±7.3 (43-83) years, and the mean PSA value was 12.5±18.3 (0.6-142) ng/dL. Prostate cancer detection rate was 22.7%. The mean VAS-1 score in Group 1 and group 2 was 1.6±1.8 and 2.0±2.5, respectively (p=0.209). The mean VAS-2 score in Group 1 and Group 2 was 2.5±2.4 and 2.6±2.6, respectively (p=0,725). Conclusion: The pain felt during TRUS-PBx is not related with the presence of prostate cancer on biopsy pathology.","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"86-89"},"PeriodicalIF":0.2,"publicationDate":"2016-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70977903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Importance of the Re-Transurethral Resection in Bladder Cancer Treatment 再次经尿道膀胱切除术在膀胱癌治疗中的重要性
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-23 DOI: 10.4274/UOB.703
F. Narter, F. Tarhan, Erkin Sağlam, K. Erdem, Övünç Kavukoğlu, E. Çamur, G. Faydaci
{"title":"Importance of the Re-Transurethral Resection in Bladder Cancer Treatment","authors":"F. Narter, F. Tarhan, Erkin Sağlam, K. Erdem, Övünç Kavukoğlu, E. Çamur, G. Faydaci","doi":"10.4274/UOB.703","DOIUrl":"https://doi.org/10.4274/UOB.703","url":null,"abstract":"","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"94-97"},"PeriodicalIF":0.2,"publicationDate":"2016-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70977777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Uroonkoloji Bulteni-Bulletin of Urooncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1